Search - tctmd.com

Displaying 1 - 20 of 224

Sort: Relevancy | Date

News Daily News

Telemedicine May Adversely Impact Care Quality for HF Patients

Caitlin E. Cox

January 26, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Todd Neale

November 14, 2025

News Conference News HFSA 2025

Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74

Yael L. Maxwell

September 30, 2025

News Conference News HFSA 2025

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

Yael L. Maxwell

September 29, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Conference News ESC Heart Failure 2025

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

Todd Neale

May 20, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Lower Risk of Mortality for Shock Patients Transferred to Expert Centers

Caitlin E. Cox

March 17, 2025

Advertisement

Telemedicine May Adversely Impact Care Quality for HF Patients

Heart Disease Remains Number One Killer of Americans

HF Care Differs Among Asian Subgroups in the US

JACC Debuts Data Digest on CV Health in the United States

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

FDA Approves Aficamten for Obstructive HCM

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

July 2025 Dispatch for the CV Team

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

March 2025 Dispatch for the CV Team

Lower Risk of Mortality for Shock Patients Transferred to Expert Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content